US penalises Zimmer Biomet for repeat foreign bribery violations
Indiana-based medical device manufacturer Zimmer Biomet agreed on 12 January to pay a US$17.4 million criminal penalty after breaching the terms of a 2012 Foreign Corrupt Practices Act deferred prosecution agreement.
To read more
Subscribe to Global Investigations Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Investigations Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10